Surgical Versus Medical Interventions in CRS and Nasal Polyps: Comparative Evidence Between Medical and Surgical Efficacy

Current Allergy and Asthma Reports

Volumn 15, Issue 11, 2015, Pages

  Dessouky, Osama ^a   Hopkins, Claire ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Cost effectiveness; CRS with nasal polyps (CRSwNP); Endoscopic sinus surgery (ESS); Medical management; Polypectomy; Quality of life; Timing of surgery

Indexed keywords

ACETYLSALICYLIC ACID; BUDESONIDE; CLARITHROMYCIN; DOXYCYCLINE; FLUTICASONE PROPIONATE; MEPOLIZUMAB; MOMETASONE FUROATE; MONTELUKAST; OMALIZUMAB; PREDNISOLONE; RESLIZUMAB; ROXITHROMYCIN; STEROID; ZAFIRLUKAST;

ANAPHYLAXIS; CATARACT; CHRONIC RHINOSINUSITIS; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DRUG HYPERSENSITIVITY; DRY NOSE; ENDOSCOPIC SINUS SURGERY; EPISTAXIS; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTRANSAMINASEMIA; IMPAIRED GLUCOSE TOLERANCE; MIDDLE TURBINATE; MOOD DISORDER; NEOPLASM; NOSE IRRITATION; NOSE POLYP; OSTEOPOROSIS; POLYPECTOMY; PREVALENCE; PRURITUS; RASH; REVIEW; RHINOPHARYNGITIS; SKIN IRRITATION; SORE THROAT; STOMACH DISEASE; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; TREMOR; TURBINATE; CHRONIC DISEASE; LARYNGOSCOPE; NASAL POLYPS; RHINITIS; SINUSITIS;

CHRONIC DISEASE; HUMANS; LARYNGOSCOPES; NASAL POLYPS; PREVALENCE; RHINITIS; SINUSITIS;

EID: 84942793025     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-015-0566-5     Document Type: Review

References (67)

1. Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe—an underestimated disease. A GA2LEN study. Allergy. 2011;66:1216–23.
2. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;23:1–298. Comprehensive review of the literature with evidence based treatment algorithms.
3. Hopkins C, Browne JP, Slack R, Lund V, Topham J, Reeves B, et al. The national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Clin Otolaryngol. 2006;31:390–8.
4. Larsen K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc. 1996;17:243–9.
5. Rugina M, Serrano E, Klossek JM, Crampette L, Stoll D, Bebear JP, et al. Epidemiological and clinical aspects of nasal polyposis in France; the ORLI group experience. Rhinology. 2002;40(2):75–9.
6. Larsen PL, Tos M. Nasal polyps: epithelium and goblet cell density. Laryngoscope. 1989;99(12):1274–80.
7. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep. 2005;5(6):463–71.
8. Kalish L, Snidvongs K, Sivasubramaniam R, Cope D, Harvey RJ. Topical steroids for nasal polyps. Cochrane Database Syst Rev. 2012;12:CD006549.
9. van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology. 1994;32(1):5–9.
10. Vaidyanathan S, Barnes M, Williamson P, Hopkinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med. 2011;154(5):293–302.
11. Lildholt T. Surgical versus medical treatment of nasal polyps. Rhinol Suppl. 1989;8:31–3.
12. Slavin RG. Nasal polyps and sinusitis. JAMA. 1997;278(22):1849–54.
13. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–76.
14. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol. 2000;14(3):143–8.
15. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med. 1997;182(2):115–24.
16. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116(2):189–93.
17. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131:110–6 e1.
18. Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006;118(5):1133–41.
19. Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;27.
20. Ragab S, Parikh A, Darby YC, Scadding GK. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2001;31(9):1385–91.
21. Kieff DA, Busaba NY. Efficacy of montelukast in the treatment of nasal polyposis. Ann Otol Rhinol Laryngol. 2005;114(12 I):941–5.
22. Lee RU, Stevenson DD. Aspirin exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res. 2011;3(1):3–10.
23. Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-Term Outcomes From the English National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis. Laryngoscope. 2009;119(12):2459–65.
24. Sindwani R, Manz R. Technological innovations in tissue removal during rhinologic surgery. Am J Rhinol Allergy. 2012;26(1):65–9.
25. Tirelli G, Gatto A, Spinato G, Tofanelli M. Surgical treatment of nasal polyposis: a comparison between cutting forceps and microdebrider. Am J Rhinol Allergy. 2013;27(6):e202–6.
26. Kumar N, Sindwani R. Bipolar microdebrider may reduce intraoperative blood loss and operating time during nasal polyp surgery. Ear Nose Throat J. 2012;91(8):336–44.
27. Comet M, Reinart S, Georgalas C, et al. The microdebrider—a step forward or an expensive gadget. Rhinology. 2012;50:191–8.
28. Larsen K, Tos M. A long-term follow-up study of nasal polyp patients after simple polypectomies. Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S85–8.
29. Rudmik L, Smith KA, Kilty S. Endoscopic Polypectomy in the Clinic (EPIC): A Pilot Cost-Effectiveness Analysis. Clin Otolaryngol. doi:10.1111/coa.12473.
30. Browne JP, Hopkins C, Slack R, Topham J, Reeves B, Lund V, et al. Health-related quality of life after polypectomy with and without additional surgery. Laryngoscope. 2006;116(2):297–302.
31. Masterson L, Tanweer F, Bueser T, Leong P. Extensive endoscopic sinus surgery: does this reduce the revision rate for nasal polyposis? Eur Arch Otorhinolaryngol. 2010;267(10):1557–61.
32. DeConde AS, Suh JD, Mace JC, Alt JA, Smith TL. Outcomes of complete vs targeted approaches to endoscopic sinus surgery. Int Forum Allergy Rhinol. 2015;5(8):691–700.
33. Chin D, Harvey RJ. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment. Curr Opin Otolaryngol Head Neck Surg. 2013;21(1):23–30.
34. Jankowski R, Pigret D, Decroocq F, Blum A, Gillet P. Comparison of radical (nasalisation) and functional ethmoidectomy in patients with severe sinonasal polyposis. Rev Laryngol Otol Rhinol (Bord). 2006;127(3):131–40.
35. Sharma R, Rimmer J, Hopkins C. Surgical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Libarary Syst Rev. 2014;11:CD006990. doi:10.1002/14651858.CD006990.pub2.
36. Hopkins C, Browne JP, Slack R, Lund VJ, Topham J, Reeves BC, et al. Complications of surgery for nasal polyposis and chronic rhinosinusitis: the results of a National Audit in England and Wales. Laryngoscope. 2006;116:1494–9.
37. May M, Levine HL, Mester SJ, Schaitkin B. Complications of endoscopic sinus surgery: analysis of 2108 patients-incidence and prevention. Laryngoscope. 1994;104(9):1080–3.
38. Dalziel K, Stein K, Round A, Garside R, Royle P. Endoscopic sinus surgery for the excision of nasal polyps: a systematic review of safety and effectiveness. Am J Rhinol. 2006;20(5):506–19.
39. Justice JM, Orlandi RR. An update on attitudes and use of image-guided surgery. Int Forum Allergy Rhinol. 2012;2:155–9.
40. Dalgorf DM, Sacks R, Wormald PJ, Naidoo Y, Panizza B, Uren B, et al. Image-guided surgery influences perioperative morbidity from endoscopic sinus surgery: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013;149(1):17–29.
41. Rimmer J, Fokkens W, Chong L, Hopkins C. Surgical versus medical interventions for CRS with nasal polyps. Cochrane Database Syst Rev. 2014;12:CD006991. doi:10.1002/14651858.CD006991.pub2. Detailed description and evaluation of comparative studies.
42. Alobid I, Benítez P, Bernal-Sprekelsen M, Roca J, Alonso J, Picado C, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy. 2005;60:452–8.
43. Lildholt T, Fogstrup J, Gammelgaard N, Kortholm B, Ulsoe C. Surgical versus medical treatment of nasal polyps. Acta Otolaryngol. 1988;105(1–2):140–3.
44. Lildholt T. Surgical versus medical management of nasal polyps. Rhinology. 1989;27(S8):31–3.
45. Ragab SM, Lund VJ, Scadding G, Saleh HA, Khalifa MA. Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial. Rhinology. 2010;48(3):305–11.
46. Blomqvist EH, Lundblad L, Bergstedt H, Stjärne P. A randomized prospective study comparing medical and medical-surgical treatment of nasal polyposis by CT. Acta Otolaryngol. 2009;129:545–9.
47. Blomqvist EH, Lundblad L, Anggård A, Haraldsson PO, Stjärne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol. 2001;107(2):224–8.
48. Jankowski R, Bodino C. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalisation). Rhinology. 2003;41(4):220–30.
49. Baradaranfar MH, Ahmadi ZS, Dadgarnia MH, Bemanian MH, Atighechi S, Karimi G, et al. Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis. Eur Arch Otorhinolaryngol. 2014;271(2):311–6.
50. Smith T, Kern B, Palmer J, et al. Medical therapy versus surgery for CRS: a prospective, multi-institutional study. Int Forum Allergy Rhinol. 2011;1:235–41.
51. Luk LJ, Steele TO, Mace JC, Soler ZM, Rudmik L, Smith TL. Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional study. Int Forum Allergy Rhinol. 2015;3. doi:10.1002/alr.21588.
52. DeConde AS, Mace JC, Alt JA, Schlosser RJ, Smith TL, Soler ZM. Comparative effectiveness of medical and surgical therapy on olfaction in chronic Rhinosinusitis: a prospective, multi-institutional study. Int Forum Allergy Rhinol. 2014;4:725–33.
53. Smith KA, Smith TL, Mace JC, Rudmik L. Endoscopic sinus surgery compared to continued medical therapy for patients with refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(10):823–7.
54. Leung RM, Dinnie K, Smith TL. When do the risks of repeated courses of corticosteroids exceed the risks of surgery? Int Forum Allergy Rhinol. 2014;4(11):871–6.
55. Rix I, Håkansson K, Larsen CG, Frendø M, von Buchwald C. Management of chronic rhinosinusitis with nasal polyps and coexisting asthma: a systematic review. Am J Rhinol Allergy. 2015;29(3):193–201.
56. Ragab S, Scadding GK, Lund VJ, Saleh H. Treatment of chronic rhinosinusitis and its effects on asthma. Eur Respir J. 2006;28:68–74.
57. Hopkins C, Rimmer J, Lund VJ. Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis. Rhinology. 2015;53:10–7.
58. Hopkins C, Andrews P, Holy CE. Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Retrospective analysis using the UK clinical practice research data. Rhinology. 2015;53:18–24.
59. Benninger MS, Sindwani R, Holy CE, Hopkins C. Early versus delayed endoscopic sinus surgery in patients with chronic rhinosinusitis: impact on health care utilization. Otolaryngol Head Neck Surg. 2015;152(3):546–52.
60. Rudmik L, Soler ZM, Mace JC, Schlosser RJ, Smith TL. Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015;125(1):25–32. Excellent paper evaluating the relative cost-effectiveness of medical versus surgical treatment.
61. Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol. 2011;120(7):423–7.
62. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat. 1999;200:1–203.
63. Sahlstrand-Johnson P, Ohlsson B, Von Buchwald C, Jannert M, Ahlner-Elmqvist M. A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology. 2011;49(4):420–8.
64. Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol Head Neck Surg. 2011;144(3):440–5.
65. Bernic A, Dessouky O, Philpott S, Morris S, Hopkins C. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis. Curr Otorhinolaryngol Rep. 2015;3(2):117–23.
66. Benninger MS, Holy CE. Endoscopic sinus surgery provides effective relief as observed by health care use pre- and postoperatively. Otolaryngol Head Neck Surg. 2014;150(5):893–900.
67. Rudmik L, Mace J, Soler ZM, Smith TL. Long-term utility outcomes in patients undergoing endoscopic sinus surgery. Laryngoscope. 2014;124(1):19–23.